Bristol-Myers Squibb Co. (BMY)

50.90
0.33 0.65
NYSE : Health Technology
Prev Close 50.57
Open 50.71
Day Low/High 50.61 / 51.03
52 Wk Low/High 42.48 / 63.69
Volume 939.34K
Avg Volume 12.47M
Exchange NYSE
Shares Outstanding 1.64B
Market Cap 81.90B
EPS 3.00
P/E Ratio 13.09
Div & Yield 1.64 (3.27%)
Intermediate Trade: Bristol-Myers Squibb

Intermediate Trade: Bristol-Myers Squibb

The trade is the out-of-the-money, bullishly biased vertical call spread expiring in August.

3 Fearless Predictions for the Second Half

3 Fearless Predictions for the Second Half

The FAANG stocks will underperform, banks will do well and biotech merger action will pick up.

3 Fearless Predictions for the Second Half

3 Fearless Predictions for the Second Half

The FAANG stocks will underperform, banks will do well and biotech merger action will pick up.

Cramer: Stop Talking About the 'Market'

Cramer: Stop Talking About the 'Market'

It just isn't as useful or descriptive right now.

Cramer: You Can't Bet Against the Bonds

Cramer: You Can't Bet Against the Bonds

A rotation that started as the minor chord of the rotational symphony and is now the major one.

Intermediate Level Trade: BMY

Intermediate Level Trade: BMY

I prefer a bullishly biased vertical call spread.

Cramer: You Need 2 Monday Morning Game Plans

Cramer: You Need 2 Monday Morning Game Plans

We really want to shake out the weak hands here.

Cramer: 15 Stocks to Buy for the Triathlon of Fear Coming on Super-Thursday

Cramer: 15 Stocks to Buy for the Triathlon of Fear Coming on Super-Thursday

The handwringers will be out in full force. Their fear creates buying opportunities.

Cramer: Carl Icahn Was Right to Sell Apple at $95

Cramer: Carl Icahn Was Right to Sell Apple at $95

What's right for a hedge fund manager sitting on a big gain, isn't necessarily right for you.

U.S. Steel is Glad This Week is Over

Let the weekend begin and may Day 2 and 3 of the NFL draft bring my Arizona Cardinals some undervalued gems on both sides of the bay. Great filling for Doug Kass over the past couple of days. Look forward to doing it again. Fairly uneventful few day...

Cramer: When Oil Falls, These Dominoes Get Hit

Cramer: When Oil Falls, These Dominoes Get Hit

It doesn't look like Washington will be much help.

A Trio of Stocks Up on Nice Results

The market is off to a decent start as investors try to digest scores of first-quarter earnings reports. Bristol-Myers Squibb is just one of many large-cap drug and biotech companies reporting today. BMY shares are up as earnings and revenue easily ...

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.

Rally Comes With Reasons for Concern

Rally Comes With Reasons for Concern

S&P is already at resistance levels, where the advance appeared to stall.

Intermediate Trade: Bristol-Myers Squibb

Intermediate Trade: Bristol-Myers Squibb

Consider this BMY bullishly biased, near-the-money vertical call spread.

Takeaways and Observations (Early Edition)

"Doug Kass wrote an article today about how he fears the lack of fear in this market. I agree with Doug that lack of fear is an issue, but it goes further than that. What this market has missed for quite some time is strong emotion. There may not be...

Jim Cramer Says Incyte Has an Amazing Pipeline of Treatments

Jim Cramer Says Incyte Has an Amazing Pipeline of Treatments

'These companies are all assessing the Trump effect,' Cramer said.

Cramer: Stay the Course, but Keep Cash Handy

Cramer: Stay the Course, but Keep Cash Handy

It's pretty normal to have profit-taking after such a strong first quarter.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

The Good, the Bad and the Ugly (2:00 p.m. Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, "The Good, the Bad and the Ugly" Its been a long week, so there will be no "Takeaways." Let's move to the abbreviated Monarch Notes for...

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Stocks churn around the flatline to end the week as a selloff in health care counters gains seen elsewhere.

Today's Takeaways and Observations (Early Edition)

"I would describe today's market action as "benign." And that applies to almost every asset class." -- Kass Diary 104 trading sessions without a one percent drop in the indices. "Don't Think the Machines Could Turn to Selling? You've Forgotten 1987....

Cramer: Don't Give the Fed Credit

Cramer: Don't Give the Fed Credit

Most of the 10 best stocks of the bull market did it their way.

Takeaways and Observations

  "Wishin' and hopin' And thinkin' and prayin'..."  -- Dusty Springfield, Wishin' and Hopin'  The gap from last week's presidential speech was filled this afternoon.  I am more negative than most and more negative than I have been in a while.  Liter...

Cowen Health Care Conf.

What You Should Know About OncoSec's IL-12 Melanoma Immunotherapy

What You Should Know About OncoSec's IL-12 Melanoma Immunotherapy

In a 24-week trial of 22 patients, OncoSec saw a 41% response rate

Is This the Start of a Downturn?

Is This the Start of a Downturn?

There has been a very narrow trading range and a lack of price movement.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.